0001231919-23-000001.txt : 20230106 0001231919-23-000001.hdr.sgml : 20230106 20230106160540 ACCESSION NUMBER: 0001231919-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230106 DATE AS OF CHANGE: 20230106 EFFECTIVENESS DATE: 20230106 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Outlook Therapeutics, Inc. CENTRAL INDEX KEY: 0001649989 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 383982704 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-469961 FILM NUMBER: 23515100 BUSINESS ADDRESS: STREET 1: 485 ROUTE 1 SOUTH STREET 2: BUILDING F, SUITE 320 CITY: ISELIN STATE: NJ ZIP: 08830 BUSINESS PHONE: 6096193990 MAIL ADDRESS: STREET 1: 485 ROUTE 1 SOUTH STREET 2: BUILDING F, SUITE 320 CITY: ISELIN STATE: NJ ZIP: 08830 FORMER COMPANY: FORMER CONFORMED NAME: Oncobiologics, Inc. DATE OF NAME CHANGE: 20150804 D 1 primary_doc.xml X0708 D LIVE 0001649989 Outlook Therapeutics, Inc. 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ NEW JERSEY 08830 609-619-3990 DELAWARE Oncobiologics, Inc. Corporation true Randy H. Thurman c/o Outlook Therapeutics, Inc. 485 Route 1 South, Bldg. F, Suite 320 Iselin NJ NEW JERSEY 08830 Director Yezan Haddadin c/o Outlook Therapeutics, Inc. 485 Route 1 South, Bldg. F, Suite 320 Iselin NJ NEW JERSEY 08830 Director Kurt J. Hilzinger c/o Outlook Therapeutics, Inc. 485 Route 1 South, Bldg. F, Suite 320 Iselin NJ NEW JERSEY 08830 Director Lawrence A. Kenyon c/o Outlook Therapeutics, Inc. 485 Route 1 South, Bldg. F, Suite 320 Iselin NJ NEW JERSEY 08830 Executive Officer Director Faisal G. Sukhtian c/o Outlook Therapeutics, Inc. 485 Route 1 South, Bldg. F, Suite 320 Iselin NJ NEW JERSEY 08830 Director Andong Huang c/o Outlook Therapeutics, Inc. 485 Route 1 South, Bldg. F, Suite 320 Iselin NJ NEW JERSEY 08830 Director Gerd Auffarth c/o Outlook Therapeutics, Inc. 485 Route 1 South, Bldg. F, Suite 320 Iselin NJ NEW JERSEY 08830 Director Julian Gangolli c/o Outlook Therapeutics, Inc. 485 Route 1 South, Bldg. F, Suite 320 Iselin NJ NEW JERSEY 08830 Director Julia A. Haller c/o Outlook Therapeutics, Inc. 485 Route 1 South, Bldg. F, Suite 320 Iselin NJ NEW JERSEY 08830 Director C. Russell Trenary c/o Outlook Therapeutics, Inc. 485 Route 1 South, Bldg. F, Suite 320 Iselin NJ NEW JERSEY 08830 Executive Officer Director Biotechnology Decline to Disclose 06b false 2022-12-28 false true true false 0 31820000 31820000 0 Consists of an unsecured convertible promissory note with a face amount of $31,820,000, reflecting an original issue discount of $1,800,000. false 1 0 0 0 false Outlook Therapeutics, Inc. /s/ Lawrence Kenyon Lawrence Kenyon Chief Financial Officer, Treasurer and Secretary 2023-01-06